Swagata Kar, PhD Recently Promoted to Vice President of Marketing for BIOQUAL, Inc.
May 23, 2024
| BioBuzz has been building life science communities for 14 years because we believe in the power of personal networks to unlock your career potential. For our next chapter, we’re building upon the success of our community to help solve today’s greatest challenges in hiring and career development. There is a better, more equitable way to connect talent with opportunity… and we’re building it. |
Gaithersburg, MD-based BIOQUAL, Inc., a contract research service focused on in vivo models of human diseases including COVID-19, AIDS, influenza, Mpox, RSV infection, Flavivirus infections including Zika and Dengue, malaria, hepatitis, and cancer, has recently promoted Swagata Kar, PhD to Vice President of Marketing. BIOQUAL has laboratories and vivariums under both BSL-2 and BSL-3 containment. In addition, BIOQUAL maintains CDC-approved BSL-3 containment laboratories for studies associated with Select Agents including highly pathogenic avian influenza, Mpox and SARS-CoV.
Dr. Kar has been with BIOQUAL for over eight years and is the current Vice President for Preclinical Models and Services. In addition to her duties as Vice President for Preclinical Models and Services, Dr. Kar is now also responsible for increasing company brand awareness through the development and implementation of cohesive marketing and PR strategies for BIOQUAL, Inc as the new Vice President of Marketing.
About Dr. Swagata Kar
Dr. Swagata Kar received her Bachelor of Science in Microbiology and Master of Science in Zoology (Molecular Biology) from the University of Pune, India, and her PhD from Uniformed Services University of Health Sciences (Bethesda, MD). Her PhD thesis research project focused on determining the mechanism of innate and humoral immune responses to polysaccharide, protein and bacterial antigens, and vaccines in mouse models of Streptococcus pneumoniae. Dr. Kar transitioned to studying cancer immunotherapy using rodent tumor models, as a postdoctoral fellow, at the Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick. Prior to her PhD, she served as a Research Fellow at the National Institute of Virology, India, and later worked as a Biologist in the Lab of Malaria Immunology, NIAID, NIH.
In 2016, Dr. Kar joined BIOQUAL, Inc. as a Staff Scientist. She was promoted to Research Director in 2020 and then to Vice President, Preclinical Models and Services in early 2023. She has 15+ years of experience with preclinical animal models and immunoassays. Dr. Kar has been actively working on introducing and establishing new animal models of cancer and infectious diseases for preclinical testing at BIOQUAL, Inc. She has also served as a subject matter expert, consultant, and co-investigator on various collaborative grant submissions. In her role as Vice President, Preclinical Models and Services, she is responsible for identifying new business avenues, managing the overall research operations of the preclinical testing utilizing small animal models, and in vitro testing.
About BIOQUAL, Inc.
BIOQUAL, Inc. (BIOQUAL) was established in 1981 to perform contract research services focused on in vivo models of human diseases. Our models span a wide range of prevalent infectious diseases including (among others) COVID-19, influenza, RSV, HIV, Zika, Dengue, Malaria, MRSA and Mpox. BIOQUAL specializes in delivering individually tailored models for current and emerging diseases. These services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. In addition to infectious diseases, our model services now include syngeneic mouse tumor allograft and select human cell line derived xenograft (CDX) models. Our laboratories and vivarium are available for level 3 biocontainment, including studies of Select Agents. Service offerings are focused on meeting client needs regardless of animal model or specific disease type and delivery of downstream expertise throughout the process.
For more on BIOQUAL, Inc., visit: https://www.bioqual.com/
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
